New Migraine Drugs Show Promise
WEDNESDAY, Nov. 29, 2017 (HealthDay News) -- Two new migraine drugs have shown promise in late-stage clinical trials.
The drugs were designed specifically to target a pathway believed to be important in these headaches.
In stage 3 clinical trials, the drugs were found to work exceptionally well for some people, but not as well for others. Still, headache experts are enthused about the new research.
https://medlineplus.gov/news/fullstory_170036.html